Method and composition for hyperthermally treating cells
US-9017729-B2 · Apr 28, 2015 · US
US9730635B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9730635-B2 |
| Application number | US-201313924145-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2013 |
| Priority date | Jun 21, 2013 |
| Publication date | Aug 15, 2017 |
| Grant date | Aug 15, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A wearable device includes a detector configured to detect a response signal transmitted from a portion of subsurface vasculature, the response signal being related to binding of a clinically-relevant analyte to functionalized particles present in a lumen of the subsurface vasculature. Program instructions stored in a computer readable medium of the device, and executable by a processor, may cause the device to determine a concentration of the clinically-relevant analyte based on the response signal detected by the detector; determine whether a medical condition is indicated based on at least the concentration of the clinically-relevant analyte; and, in response to a determination that the medical condition is indicated, transmit data representative of the medical condition via the communication interface. The device may also include a signal source configured to transmit an interrogating signal into the portion of subsurface vasculature, thereby generating a response signal in response to the interrogating signal.
Opening claim text (preview).
What is claimed is: 1. A wearable device, comprising: a mount for mounting the wearable device to an external surface of a body proximate to a portion of subsurface vasculature; a magnet; a detector; a communication interface; a processor; a non-transitory computer-readable medium; and program instructions stored in the non-transitory computer-readable medium, wherein the program instructions are executable by the processor to cause the wearable device to perform functions comprising: operating the magnet to direct a magnetic field into the portion of subsurface vasculature, wherein the magnetic field causes functionalized magnetic nanoparticles that have been introduced into the body to collect in a lumen of the portion of subsurface vasculature, wherein the functionalized magnetic nanoparticles each comprise an antibody and a marker, wherein the marker is a fluorophore, an autofluorescent marker, a luminescent marker, or a chemo-luminescent marker, and wherein the marker produces fluorescence radiation indicative of an analyte; operating the detector to detect the fluorescence radiation produced by the marker in the functionalized magnetic nanoparticles collected in the lumen of the subsurface vasculature by the magnetic field; using the fluorescence radiation detected by the detector to detect a presence of the analyte; determining whether the presence of the analyte indicates a medical condition; and in response to a determination that the medical condition is indicated, transmitting data representative of the medical condition via the communication interface. 2. The wearable device of claim 1 , wherein the external surface of the body comprises a wrist. 3. The wearable device of claim 2 , wherein the mount comprises a wristband or cuff. 4. The wearable device of claim 1 , wherein the functions further comprise: using the fluorescence radiation detected by the detector to determine a concentration of the analyte; and determining whether the concentration of the analyte indicates a medical condition. 5. The wearable device of claim 1 , further comprising: a signal source, wherein the functions further comprise operating the signal source to transmit an interrogating signal into the portion of subsurface vasculature, wherein the fluorescence radiation is produced in response to the interrogating signal. 6. The wearable device of claim 5 , wherein the interrogating signal comprises electromagnetic radiation having a wavelength between about 400 nanometers and about 1600 nanometers. 7. The wearable device of claim 6 , wherein the interrogating signal comprises electromagnetic radiation having a wavelength between about 500 nanometers and about 1000 nanometers. 8. The wearable device of claim 6 , wherein the marker in the functionalized magnetic nanoparticles is a fluorophore. 9. The wearable device of claim 1 , wherein the marker in the functionalized magnetic nanoparticles is a chemo-luminescent marker. 10. The wearable device of claim 1 , further comprising: a user interface, wherein the functions further comprise: reporting the presence of the analyte via the user interface. 11. The wearable device of claim 10 , wherein the functions further comprise: in response to a determination that the medical condition is indicated, generating an alert via the user interface. 12. The wearable device of claim 5 , wherein the functions further comprise: controlling the signal source to transmit interrogating signals at preset measurement times; receiving, from the detector, data representative of fluorescence radiation transmitted from the portion of subsurface vasculature in response to the interrogating signals transmitted at the preset measurement times; for each preset measurement time, using the fluorescence radiation detected by the detector at that measurement time to detect the presence of the analyte; and determining, for each preset measurement time, whether the presence of the analyte indicates the medical condition. 13. The wearable device of claim 12 , wherein the functions further comprise: for each preset measurement time, using the fluorescence radiation detected by the detector at that measurement time to determine a corresponding concentration of the analyte; and determining, for each preset measurement time, whether the corresponding concentration of the analyte indicates the medical condition. 14. The wearable device of claim 1 , wherein the magnet is an electromagnet.
using optical sensors, e.g. spectral photometrical oximeters · CPC title
Wristwatch-type devices · CPC title
Monitoring a patient using a global network, e.g. telephone networks, internet · CPC title
Simultaneously evaluating both cardiovascular condition and temperature · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.